Global Microbiome Therapeutics Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Publisher Name :
Date: 09-Feb-2018
No. of pages: 107

The human microbiome is the collection of all the microorganisms living in association with the human body. These communities consist of a variety of microorganisms including eukaryotes, archaea, bacteria and viruses. Bacteria in an average human body number ten times more than human cells, for a total of about 1000 more genes than are present in the human genome. Because of their small size, however, microorganisms make up only about 1 to 3 percent of our body mass (that's 2 to 6 pounds of bacteria in a 200-pound adult).

Scope of the Report:

This report focuses on the Microbiome Therapeutics in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.

Market Segment by Manufacturers, this report covers

- Seres Therapeutics

- Assembly Biosciences

- Synthetic Biologics

- Interxon

- PureTech

- Synlogic

- Enterome BioScience

- 4D Pharma

- Second Genome

- AOBiome

- C3 Jian

- Rebiotix

- MicroBiome Therapeutics LLC

- Metabiomics

- Ritter Pharmaceuticals

- Symberix

- OpenBiome

- Azitra

- Symbiotix Biotherapies

- Osel

- Metabogen

Market Segment by Regions, regional analysis covers

- North America (United States, Canada and Mexico)

- Europe (Germany, France, UK, Russia and Italy)

- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

- South America (Brazil, Argentina, Colombia)

- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Market Segment by Applications, can be divided into

- C. difficile Infection (CDI)

- Inflammatory Bowel Disease (IBD)

- Orphan Drug

- Immuno-oncology

- Others

There are 15 Chapters to deeply display the global Microbiome Therapeutics market.

Chapter 1, to describe Microbiome Therapeutics Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Microbiome Therapeutics, with sales, revenue, and price of Microbiome Therapeutics, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Microbiome Therapeutics, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Microbiome Therapeutics market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Microbiome Therapeutics sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Global Microbiome Therapeutics Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Table of Contents

1 Market Overview
1.1 Microbiome Therapeutics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 C. difficile Infection (CDI)
1.3.2 Inflammatory Bowel Disease (IBD)
1.3.3 Orphan Drug
1.3.4 Immuno-oncology
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market Status and Outlook (2013-2023)
1.4.1.2 Canada Market Status and Outlook (2013-2023)
1.4.1.3 Mexico Market Status and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market Status and Outlook (2013-2023)
1.4.2.2 France Market Status and Outlook (2013-2023)
1.4.2.3 UK Market Status and Outlook (2013-2023)
1.4.2.4 Russia Market Status and Outlook (2013-2023)
1.4.2.5 Italy Market Status and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market Status and Outlook (2013-2023)
1.4.3.2 Japan Market Status and Outlook (2013-2023)
1.4.3.3 Korea Market Status and Outlook (2013-2023)
1.4.3.4 India Market Status and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market Status and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market Status and Outlook (2013-2023)
1.4.4.2 Egypt Market Status and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market Status and Outlook (2013-2023)
1.4.4.4 South Africa Market Status and Outlook (2013-2023)
1.4.4.5 Nigeria Market Status and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Seres Therapeutics
2.1.1 Business Overview
2.1.2 Microbiome Therapeutics Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Assembly Biosciences
2.2.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Synthetic Biologics
2.3.1 Business Overview
2.3.2 Microbiome Therapeutics Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Interxon
2.4.1 Business Overview
2.4.2 Microbiome Therapeutics Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 PureTech
2.5.1 Business Overview
2.5.2 Microbiome Therapeutics Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Synlogic
2.6.1 Business Overview
2.6.2 Microbiome Therapeutics Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Enterome BioScience
2.7.1 Business Overview
2.7.2 Microbiome Therapeutics Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 4D Pharma
2.8.1 Business Overview
2.8.2 Microbiome Therapeutics Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Second Genome
2.9.1 Business Overview
2.9.2 Microbiome Therapeutics Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AOBiome
2.10.1 Business Overview
2.10.2 Microbiome Therapeutics Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 C3 Jian
2.11.1 Business Overview
2.11.2 Microbiome Therapeutics Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Rebiotix
2.12.1 Business Overview
2.12.2 Microbiome Therapeutics Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 MicroBiome Therapeutics LLC
2.13.1 Business Overview
2.13.2 Microbiome Therapeutics Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Metabiomics
2.14.1 Business Overview
2.14.2 Microbiome Therapeutics Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Ritter Pharmaceuticals
2.15.1 Business Overview
2.15.2 Microbiome Therapeutics Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Symberix
2.16.1 Business Overview
2.16.2 Microbiome Therapeutics Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 OpenBiome
2.17.1 Business Overview
2.17.2 Microbiome Therapeutics Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Azitra
2.18.1 Business Overview
2.18.2 Microbiome Therapeutics Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Symbiotix Biotherapies
2.19.1 Business Overview
2.19.2 Microbiome Therapeutics Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Osel
2.20.1 Business Overview
2.20.2 Microbiome Therapeutics Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 Metabogen
2.21.1 Business Overview
2.2.2 Microbiome Therapeutics Type and Applications
2.21.2.1 Type 1
2.21.2.2 Type 2
2.21.3 Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Microbiome Therapeutics Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Microbiome Therapeutics Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Microbiome Therapeutics Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Microbiome Therapeutics Manufacturer Market Share
3.3.2 Top 6 Microbiome Therapeutics Manufacturer Market Share
3.4 Market Competition Trend
4 Global Microbiome Therapeutics Market Analysis by Regions
4.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Regions
4.1.1 Global Microbiome Therapeutics Sales and Market Share by Regions (2013-2018)
4.1.2 Global Microbiome Therapeutics Revenue and Market Share by Regions (2013-2018)
4.2 North America Microbiome Therapeutics Sales and Growth Rate (2013-2018)
4.3 Europe Microbiome Therapeutics Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Microbiome Therapeutics Sales and Growth Rate (2013-2018)
4.5 South America Microbiome Therapeutics Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5 North America Microbiome Therapeutics by Countries
5.1 North America Microbiome Therapeutics Sales, Revenue and Market Share by Countries
5.1.1 North America Microbiome Therapeutics Sales and Market Share by Countries (2013-2018)
5.1.2 North America Microbiome Therapeutics Revenue and Market Share by Countries (2013-2018)
5.2 United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.3 Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
5.4 Mexico Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6 Europe Microbiome Therapeutics by Countries
6.1 Europe Microbiome Therapeutics Sales, Revenue and Market Share by Countries
6.1.1 Europe Microbiome Therapeutics Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Microbiome Therapeutics Revenue and Market Share by Countries (2013-2018)
6.2 Germany Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.3 UK Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.4 France Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.5 Russia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
6.6 Italy Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7 Asia-Pacific Microbiome Therapeutics by Countries
7.1 Asia-Pacific Microbiome Therapeutics Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Microbiome Therapeutics Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Microbiome Therapeutics Revenue and Market Share by Countries (2013-2018)
7.2 China Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.3 Japan Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.4 Korea Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.5 India Microbiome Therapeutics Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8 South America Microbiome Therapeutics by Countries
8.1 South America Microbiome Therapeutics Sales, Revenue and Market Share by Countries
8.1.1 South America Microbiome Therapeutics Sales and Market Share by Countries (2013-2018)
8.1.2 South America Microbiome Therapeutics Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.3 Argentina Microbiome Therapeutics Sales and Growth Rate (2013-2018)
8.4 Colombia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9 Middle East and Africa Microbiome Therapeutics by Countries
9.1 Middle East and Africa Microbiome Therapeutics Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Microbiome Therapeutics Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Microbiome Therapeutics Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.3 UAE Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.4 Egypt Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.5 Nigeria Microbiome Therapeutics Sales and Growth Rate (2013-2018)
9.6 South Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
10 Global Microbiome Therapeutics Market Segment by Type
10.1 Global Microbiome Therapeutics Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Microbiome Therapeutics Sales and Market Share by Type (2013-2018)
10.1.2 Global Microbiome Therapeutics Revenue and Market Share by Type (2013-2018)
11 Global Microbiome Therapeutics Market Segment by Application
11.1 Global Microbiome Therapeutics Sales Market Share by Application (2013-2018)
11.2 C. difficile Infection (CDI) Sales Growth (2013-2018)
11.3 Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
11.4 Orphan Drug Sales Growth (2013-2018)
11.5 Immuno-oncology Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Microbiome Therapeutics Market Forecast (2018-2023)
12.1 Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
12.2 Microbiome Therapeutics Market Forecast by Regions (2018-2023)
12.2.1 North America Microbiome Therapeutics Market Forecast (2018-2023)
12.2.2 Europe Microbiome Therapeutics Market Forecast (2018-2023)
12.2.3 Asia-Pacific Microbiome Therapeutics Market Forecast (2018-2023)
12.2.4 South America Microbiome Therapeutics Market Forecast (2018-2023)
12.2.5 Middle East and Africa Microbiome Therapeutics Market Forecast (2018-2023)
12.3 Microbiome Therapeutics Market Forecast by Type (2018-2023)
12.3.1 Global Microbiome Therapeutics Sales Forecast by Type (2018-2023)
12.3.2 Global Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
12.4 Microbiome Therapeutics Market Forecast by Application (2018-2023)
12.4.1 Global Microbiome Therapeutics Sales Forecast by Application (2018-2023)
12.4.2 Global Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

List of Tables and Figures

Figure Microbiome Therapeutics Picture
Table Product Specifications of Microbiome Therapeutics
Figure Global Sales Market Share of Microbiome Therapeutics by Types in 2017
Table Microbiome Therapeutics Types for Major Manufacturers
Figure Microbiome Therapeutics Sales Market Share by Applications in 2017
Figure C. difficile Infection (CDI) Picture
Figure Inflammatory Bowel Disease (IBD) Picture
Figure Orphan Drug Picture
Figure Immuno-oncology Picture
Figure Others Picture
Figure United States Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure France Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure UK Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure China Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure India Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Microbiome Therapeutics Revenue (Value) and Growth Rate (2013-2023)
Table Seres Therapeutics Basic Information, Manufacturing Base and Competitors
Table Seres Therapeutics Microbiome Therapeutics Type and Applications
Table Seres Therapeutics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Assembly Biosciences Basic Information, Manufacturing Base and Competitors
Table Assembly Biosciences Microbiome Therapeutics Type and Applications
Table Assembly Biosciences Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synthetic Biologics Basic Information, Manufacturing Base and Competitors
Table Synthetic Biologics Microbiome Therapeutics Type and Applications
Table Synthetic Biologics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Interxon Basic Information, Manufacturing Base and Competitors
Table Interxon Microbiome Therapeutics Type and Applications
Table Interxon Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table PureTech Basic Information, Manufacturing Base and Competitors
Table PureTech Microbiome Therapeutics Type and Applications
Table PureTech Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Synlogic Basic Information, Manufacturing Base and Competitors
Table Synlogic Microbiome Therapeutics Type and Applications
Table Synlogic Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Enterome BioScience Basic Information, Manufacturing Base and Competitors
Table Enterome BioScience Microbiome Therapeutics Type and Applications
Table Enterome BioScience Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table 4D Pharma Basic Information, Manufacturing Base and Competitors
Table 4D Pharma Microbiome Therapeutics Type and Applications
Table 4D Pharma Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Second Genome Basic Information, Manufacturing Base and Competitors
Table Second Genome Microbiome Therapeutics Type and Applications
Table Second Genome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AOBiome Basic Information, Manufacturing Base and Competitors
Table AOBiome Microbiome Therapeutics Type and Applications
Table AOBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table C3 Jian Basic Information, Manufacturing Base and Competitors
Table C3 Jian Microbiome Therapeutics Type and Applications
Table C3 Jian Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Rebiotix Basic Information, Manufacturing Base and Competitors
Table Rebiotix Microbiome Therapeutics Type and Applications
Table Rebiotix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table MicroBiome Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Type and Applications
Table MicroBiome Therapeutics LLC Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabiomics Basic Information, Manufacturing Base and Competitors
Table Metabiomics Microbiome Therapeutics Type and Applications
Table Metabiomics Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ritter Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Ritter Pharmaceuticals Microbiome Therapeutics Type and Applications
Table Ritter Pharmaceuticals Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symberix Basic Information, Manufacturing Base and Competitors
Table Symberix Microbiome Therapeutics Type and Applications
Table Symberix Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table OpenBiome Basic Information, Manufacturing Base and Competitors
Table OpenBiome Microbiome Therapeutics Type and Applications
Table OpenBiome Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Azitra Basic Information, Manufacturing Base and Competitors
Table Azitra Microbiome Therapeutics Type and Applications
Table Azitra Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Symbiotix Biotherapies Basic Information, Manufacturing Base and Competitors
Table Symbiotix Biotherapies Microbiome Therapeutics Type and Applications
Table Symbiotix Biotherapies Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Osel Basic Information, Manufacturing Base and Competitors
Table Osel Microbiome Therapeutics Type and Applications
Table Osel Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Metabogen Basic Information, Manufacturing Base and Competitors
Table Metabogen Microbiome Therapeutics Type and Applications
Table Metabogen Microbiome Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Microbiome Therapeutics Sales by Manufacturer (2016-2017)
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2016
Figure Global Microbiome Therapeutics Sales Market Share by Manufacturer in 2017
Table Global Microbiome Therapeutics Revenue by Manufacturer (2016-2017)
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2016
Figure Global Microbiome Therapeutics Revenue Market Share by Manufacturer in 2017
Figure Top 3 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Microbiome Therapeutics Manufacturer (Revenue) Market Share in 2017
Figure Global Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Global Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Global Microbiome Therapeutics Sales by Regions (2013-2018)
Table Global Microbiome Therapeutics Sales Market Share by Regions (2013-2018)
Table Global Microbiome Therapeutics Revenue by Regions (2013-2018)
Figure Global Microbiome Therapeutics Revenue Market Share by Regions in 2013
Figure Global Microbiome Therapeutics Revenue Market Share by Regions in 2017
Figure North America Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure North America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table North America Microbiome Therapeutics Sales by Countries (2013-2018)
Table North America Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure North America Microbiome Therapeutics Sales Market Share by Countries in 2013
Figure North America Microbiome Therapeutics Sales Market Share by Countries in 2017
Table North America Microbiome Therapeutics Revenue by Countries (2013-2018)
Table North America Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure North America Microbiome Therapeutics Revenue Market Share by Countries in 2013
Figure North America Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure United States Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Canada Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Mexico Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Europe Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Europe Microbiome Therapeutics Sales by Countries (2013-2018)
Table Europe Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Table Europe Microbiome Therapeutics Revenue by Countries (2013-2018)
Table Europe Microbiome Therapeutics Revenue Market Share by Countries in 2013
Table Europe Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Germany Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure UK Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure France Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Russia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Italy Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales by Countries (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Sales Market Share by Countries 2017
Table Asia-Pacific Microbiome Therapeutics Revenue by Countries (2013-2018)
Table Asia-Pacific Microbiome Therapeutics Revenue Market Share by Countries 2017
Figure China Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Japan Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Korea Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure India Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Southeast Asia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure South America Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table South America Microbiome Therapeutics Sales by Countries (2013-2018)
Table South America Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure South America Microbiome Therapeutics Sales Market Share by Countries in 2017
Table South America Microbiome Therapeutics Revenue by Countries (2013-2018)
Table South America Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure South America Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Brazil Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Argentina Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Colombia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales by Countries (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Sales Market Share by Countries in 2017
Table Middle East and Africa Microbiome Therapeutics Revenue by Countries (2013-2018)
Table Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries in 2013
Figure Middle East and Africa Microbiome Therapeutics Revenue Market Share by Countries in 2017
Figure Saudi Arabia Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure UAE Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Egypt Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure Nigeria Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Figure South Africa Microbiome Therapeutics Sales and Growth Rate (2013-2018)
Table Global Microbiome Therapeutics Sales by Type (2013-2018)
Table Global Microbiome Therapeutics Sales Market Share by Type (2013-2018)
Table Global Microbiome Therapeutics Revenue by Type (2013-2018)
Table Global Microbiome Therapeutics Revenue Market Share by Type (2013-2018)
Table Global Microbiome Therapeutics Sales by Application (2013-2018)
Table Global Microbiome Therapeutics Sales Market Share by Application (2013-2018)
Figure Global C. difficile Infection (CDI) Sales Growth (2013-2018)
Figure Global Inflammatory Bowel Disease (IBD) Sales Growth (2013-2018)
Figure Global Orphan Drug Sales Growth (2013-2018)
Figure Global Immuno-oncology Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Microbiome Therapeutics Sales, Revenue and Growth Rate (2018-2023)
Table Global Microbiome Therapeutics Sales Forecast by Regions (2018-2023)
Table Global Microbiome Therapeutics Market Share Forecast by Regions (2018-2023)
Figure North America Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure Europe Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure Asia-Pacific Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure South America Sales Microbiome Therapeutics Market Forecast (2018-2023)
Figure Middle East and Africa Sales Microbiome Therapeutics Market Forecast (2018-2023)
Table Global Microbiome Therapeutics Sales Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Market Share Forecast by Type (2018-2023)
Table Global Microbiome Therapeutics Sales Forecast by Application (2018-2023)
Table Global Microbiome Therapeutics Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List
  • Global and United States Clostridium Difficile Treatment Market Research by Company, Type & Application 2013-2025
    Published: 20-Oct-2018        Price: US 2000 Onwards        Pages: 111
    Summary Market Segment as follows: By Type - Narrow Spectrum Antibiotics - Broad Spectrum Antibiotics By Application - Hospitals - Clinics - Others By Company - Actelion Pharmaceuticals - Merck - Pfizer - Summit Therapeutics - Astellas Pharma - CRESTOVO - Da Volterra - Immuron - MGB Biopharma - Novartis - Otsuka Pharmaceutical ......
  • Global Biologic Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 19-Oct-2018        Price: US 3480 Onwards        Pages: 136
    Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins. Scope......
  • Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 56
    Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Inclusion Body Myositis (IBM) - Pipeline Review, H2 2018, provides an overview of the Inclusion Body Myositis (IBM) (Musculoskeletal Disorders) pipeline landscape. Inclusion Body Myositis (IBM) is one of the inflammatory myopathies that involve inflammation of the muscles or associated tissues, such as th......
  • Kidney Transplant Rejection - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 175
    Kidney Transplant Rejection - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Transplant Rejection - Pipeline Review, H2 2018, provides an overview of the Kidney Transplant Rejection (Immunology) pipeline landscape. Kidney transplantation is a therapy performed to replace a diseased kidney with a healthy kidney from another person. Risk factors associated with transplantation ......
  • Peanut Allergy - Pipeline Review, H2 2018
    Published: 16-Oct-2018        Price: US 2000 Onwards        Pages: 117
    Peanut Allergy - Pipeline Review, H2 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy - Pipeline Review, H2 2018, provides an overview of the Peanut Allergy (Immunology) pipeline landscape. Peanut allergy is common, especially in children. An allergic response to peanuts usually occurs within minutes after exposure, and symptoms range from mild to severe. Peanut allergy signs and symptoms ......
  • Global and United States Virus Like Particles Market Research by Company, Type & Application 2013-2025
    Published: 14-Oct-2018        Price: US 2000 Onwards        Pages: 117
    Summary Market Segment as follows: By Type - Adeno-Associated Virus - HIV - Hepatitis B Virus - Hepatitis C Virus - Others By Application - Vaccines - Mycoviruses - Virus Research - Therapeutic and Imaging Agents - Others By Company - GlaxoSmithKline - Merck - Novavax - Takeda - Medicago - MedImmune - TechnoVax ......
  • Global Enzyme Replacement Therapy Market Size, Status and Forecast 2018-2025
    Published: 09-Oct-2018        Price: US 3900 Onwards        Pages: 91
    This report focuses on the global Enzyme Replacement Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Enzyme Replacement Therapy development in United States, Europe and China. Enzyme replacement therapy (ERT) is a medical treatment which replaces an enzyme that is deficient or absent in the body. Usually, this is done by giving the patient an intravenous (IV) infusion of a solution containing the enzyme.......
  • Global Infantile Spasms Therapeutics Market Insights, Forecast to 2025
    Published: 09-Oct-2018        Price: US 3900 Onwards        Pages: 119
    This report studies the global market size of Infantile Spasms Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Infantile Spasms Therapeutics in these regions. This research report categorizes the global Infantile Spasms Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, f......
  • Global Gout Therapeutics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 09-Oct-2018        Price: US 3480 Onwards        Pages: 135
    Gout is a physical conditions that affects the patient's ability to move, often also termed as unwalkable disease, and it has been around for centuries. Scope of the Report: This report studies the Gout Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Gout Therapeutics market by product type and applications/en......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs